Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stasi

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Annals of Hematology|July 1, 1995
Contribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemiaR Stasi, C G Taylor, A Venditti, et al.
Journal of Internal Medicine|August 1, 1997
Efficacy and safety of human leucocyte interferon-alpha treatment in patients younger than 60 years of age with polycythaemia veraR Stasi, M Brunetti, S Bussa, et al.
Bone Marrow Transplantation|July 1, 1997
Red blood cell depletion and cryopreservation of umbilical cord blood (UCB)A Bruno, G Ballatore, G Adorno, et al.
Blood|July 10, 1998
Biological features of acute myeloid leukemia in the elderlyA Venditti, G Del Poeta, F Buccisano, et al.
Current Cancer Drug Targets|May 14, 2008
Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemiaG Del Poeta, A Bruno, M I Del Principe, et al.
Acta Haematologica|August 6, 1998
Automated haematology analysers in acute and chronic leukaemiasA Bruno, G Del Poeta, A Venditti, et al.
Annals of Hematology|April 1, 1996
Minimally differentiated acute myeloid leukemia (AML-M0): a distinct clinico-biologic entity with poor prognosisS Amadori, A Venditti, G Del Poeta, et al.
Leukemia & Lymphoma|December 24, 1997
P-glycoprotein expression in de novo acute myeloid leukemiaG Del Poeta, A Venditti, G Aronica, et al.
Leukemia Research|June 22, 1999
P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemiaG Del Poeta, A Venditti, R Stasi, et al.
Leukemia|August 5, 2005
Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia GroupsS Amadori, S Suciu, R Stasi, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Annals of Hematology|July 1, 1995
Contribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemiaR Stasi, C G Taylor, A Venditti, et al.
Journal of Internal Medicine|August 1, 1997
Efficacy and safety of human leucocyte interferon-alpha treatment in patients younger than 60 years of age with polycythaemia veraR Stasi, M Brunetti, S Bussa, et al.
Bone Marrow Transplantation|July 1, 1997
Red blood cell depletion and cryopreservation of umbilical cord blood (UCB)A Bruno, G Ballatore, G Adorno, et al.
Blood|July 10, 1998
Biological features of acute myeloid leukemia in the elderlyA Venditti, G Del Poeta, F Buccisano, et al.
Current Cancer Drug Targets|May 14, 2008
Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemiaG Del Poeta, A Bruno, M I Del Principe, et al.
Acta Haematologica|August 6, 1998
Automated haematology analysers in acute and chronic leukaemiasA Bruno, G Del Poeta, A Venditti, et al.
Annals of Hematology|April 1, 1996
Minimally differentiated acute myeloid leukemia (AML-M0): a distinct clinico-biologic entity with poor prognosisS Amadori, A Venditti, G Del Poeta, et al.
Leukemia & Lymphoma|December 24, 1997
P-glycoprotein expression in de novo acute myeloid leukemiaG Del Poeta, A Venditti, G Aronica, et al.
Leukemia Research|June 22, 1999
P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemiaG Del Poeta, A Venditti, R Stasi, et al.
Leukemia|August 5, 2005
Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia GroupsS Amadori, S Suciu, R Stasi, et al.
Pageof 8